Clinical Trial Update: Multiparametric Characterization of Colorectal Cancers (METRAD)

View source ↗

Summary

A multiparametric characterization study of colorectal cancers (METRAD) led by University Hospital, Brest is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University Hospital, Brest | Conditions: Colo-rectal Cancer | Status: ACTIVE_NOT_RECRUITING